Attached files

file filename
EX-10.1 - Emergent BioSolutions Inc.exhibit10.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
____________________
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  February 17, 2011
 
Emergent BioSolutions Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
001-33137
14-1902018
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

 
2273 Research Boulevard, Suite 400, Rockville, Maryland
20850
(Address of Principal Executive Offices)
(Zip Code)

Registrant’s telephone number, including area code:  (301) 795-1800
 
Not applicable
 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 

 

Item 1.02 Termination of a Material Definitive Agreement.
 
On February 17, 2011, Emergent BioSolutions Inc. ("Registrant") entered into a letter agreement ("Termination Agreement") with East West Resources Corporation ("EWR") terminating the Services Agreement, dated as of August 1, 2006 (“Services Agreement”), by and between the Registrant and EWR, effective as of December 30, 2010. Under the Services Agreement, EWR had provided certain transportation and logistical services to the Registrant that were substantially completed by the effective date of termination.

Item 9.01.                      Financial Statements and Exhibits.


(d)           Exhibits.

 
10.1
Letter agreement between Emergent BioSolutions Inc. and East West Resources Corporation, dated February 17, 2011

 



 
 

 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  February 23, 2011
EMERGENT BIOSOLUTIONS INC.
 
By:
/s/R. Don Elsey
R. Don Elsey
Chief Financial Officer